Informations:
Erreur:
ID
25534
Description
Study To Evaluate Beta Cell Function and Glycemic Outcome by Intensive Insulin Therapy; ODM derived from: https://clinicaltrials.gov/show/NCT00474838
Lien
https://clinicaltrials.gov/show/NCT00474838
Mots-clés
Versions (1)
- 05/09/2017 05/09/2017 -
Téléchargé le
5 septembre 2017
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Type 2 Diabetes Mellitus NCT00474838
Eligibility Type 2 Diabetes Mellitus NCT00474838
- StudyEvent: Eligibility
Similar models
Eligibility Type 2 Diabetes Mellitus NCT00474838
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Therapy naive Non-Insulin-Dependent Diabetes Mellitus | Symptoms Diabetic | Polydipsia | Polyuria | Unexplained weight loss
Item
newly diagnosed drug naïve type 2 diabetic patient with typical diabetic symptom (polydipsia, polyuria, unexplained weight loss) within recent 1 year
boolean
C0919936 (UMLS CUI [1,1])
C0011860 (UMLS CUI [1,2])
C1457887 (UMLS CUI [2,1])
C0241863 (UMLS CUI [2,2])
C0085602 (UMLS CUI [3])
C0032617 (UMLS CUI [4])
C1828173 (UMLS CUI [5])
C0011860 (UMLS CUI [1,2])
C1457887 (UMLS CUI [2,1])
C0241863 (UMLS CUI [2,2])
C0085602 (UMLS CUI [3])
C0032617 (UMLS CUI [4])
C1828173 (UMLS CUI [5])
Glycosylated hemoglobin A
Item
initial hba1c : 8.0 % ≤ hba1c < 12.0%
boolean
C0019018 (UMLS CUI [1])
Medical contraindication Insulin Glargine | Medical contraindication Insulin Glulisine | Medical contraindication Metformin | Medical contraindication glimepiride
Item
known contraindication to insulin glargine, insulin glulisine, metformin, glimepiride
boolean
C1301624 (UMLS CUI [1,1])
C0907402 (UMLS CUI [1,2])
C1301624 (UMLS CUI [2,1])
C1313386 (UMLS CUI [2,2])
C1301624 (UMLS CUI [3,1])
C0025598 (UMLS CUI [3,2])
C1301624 (UMLS CUI [4,1])
C0061323 (UMLS CUI [4,2])
C0907402 (UMLS CUI [1,2])
C1301624 (UMLS CUI [2,1])
C1313386 (UMLS CUI [2,2])
C1301624 (UMLS CUI [3,1])
C0025598 (UMLS CUI [3,2])
C1301624 (UMLS CUI [4,1])
C0061323 (UMLS CUI [4,2])
Proliferative diabetic retinopathy
Item
patients with proliferative diabetic retinopathy
boolean
C0154830 (UMLS CUI [1])
Liver disease Severe | Aspartate aminotransferase increased | Alanine aminotransferase increased
Item
severe liver disease or ast, alt ≥ 2.5 x uln
boolean
C0023895 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0151904 (UMLS CUI [2])
C0151905 (UMLS CUI [3])
C0205082 (UMLS CUI [1,2])
C0151904 (UMLS CUI [2])
C0151905 (UMLS CUI [3])
Acidosis, Lactic
Item
history of lactic acidosis
boolean
C0001125 (UMLS CUI [1])
Angina, Unstable | Angina Pectoris Severe
Item
unstable or severe angina
boolean
C0002965 (UMLS CUI [1])
C0002962 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0002962 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
Congestive heart failure
Item
congestive heart failure
boolean
C0018802 (UMLS CUI [1])
Steroid therapy Chronic disease
Item
chronic disease treated with continuous corticosteroid therapy
boolean
C0149783 (UMLS CUI [1,1])
C0008679 (UMLS CUI [1,2])
C0008679 (UMLS CUI [1,2])
Malignant Neoplasms
Item
diagnosis of cancer
boolean
C0006826 (UMLS CUI [1])
Urine pregnancy test positive | Pregnancy, Planned
Item
positive urine pregnancy test or plan to become pregnant during the clinical trial
boolean
C0430059 (UMLS CUI [1])
C0032992 (UMLS CUI [2])
C0032992 (UMLS CUI [2])